CCCC logo

C4 Therapeutics (CCCC) Cash From Operations

Annual CFO

-$106.84 M
-$899.00 K-0.85%

31 December 2023

CCCC Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

-$24.13 M
-$19.16 M-385.18%

30 September 2024

CCCC Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

-$71.23 M
+$6.57 M+8.45%

30 September 2024

CCCC TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CCCC Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.8%+21.4%+36.4%
3 y3 years-58.9%-31.5%+14.1%
5 y5 years-529.2%--

CCCC Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-58.9%at low-385.2%+27.1%at high+36.7%
5 y5 years-292.1%at low-385.2%+27.1%-327.4%+36.7%
alltimeall time-292.1%at low-385.2%+27.1%-327.4%+36.7%

C4 Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
-$24.13 M(+385.2%)
-$71.23 M(-8.4%)
June 2024
-
-$4.97 M(-72.5%)
-$77.81 M(-15.3%)
Mar 2024
-
-$18.12 M(-24.5%)
-$91.83 M(-14.0%)
Dec 2023
-$106.84 M(+0.8%)
-$24.01 M(-21.8%)
-$106.84 M(-4.6%)
Sept 2023
-
-$30.71 M(+61.6%)
-$111.96 M(+2.5%)
June 2023
-
-$19.00 M(-42.7%)
-$109.27 M(-2.8%)
Mar 2023
-
-$33.13 M(+13.7%)
-$112.47 M(+6.2%)
Dec 2022
-$105.94 M
-$29.13 M(+4.0%)
-$105.94 M(+3.4%)
Sept 2022
-
-$28.02 M(+26.2%)
-$102.48 M(+10.4%)
June 2022
-
-$22.20 M(-16.5%)
-$92.82 M(+4.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$26.60 M(+3.6%)
-$88.63 M(+1.9%)
Dec 2021
-$86.97 M(+29.3%)
-$25.67 M(+39.8%)
-$86.97 M(+4.9%)
Sept 2021
-
-$18.36 M(+2.0%)
-$82.89 M(+5.0%)
June 2021
-
-$18.00 M(-27.8%)
-$78.92 M(+4.5%)
Mar 2021
-
-$24.93 M(+15.5%)
-$75.52 M(+12.3%)
Dec 2020
-$67.25 M(-220.9%)
-$21.59 M(+50.0%)
-$67.25 M(+47.3%)
Sept 2020
-
-$14.40 M(-1.4%)
-$45.66 M(+46.1%)
June 2020
-
-$14.59 M(-12.4%)
-$31.26 M(+87.6%)
Mar 2020
-
-$16.67 M
-$16.67 M
Dec 2019
$55.61 M(-427.5%)
-
-
Dec 2018
-$16.98 M
-
-

FAQ

  • What is C4 Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for C4 Therapeutics?
  • What is C4 Therapeutics annual CFO year-on-year change?
  • What is C4 Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for C4 Therapeutics?
  • What is C4 Therapeutics quarterly CFO year-on-year change?
  • What is C4 Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for C4 Therapeutics?
  • What is C4 Therapeutics TTM CFO year-on-year change?

What is C4 Therapeutics annual cash flow from operations?

The current annual CFO of CCCC is -$106.84 M

What is the all time high annual CFO for C4 Therapeutics?

C4 Therapeutics all-time high annual cash flow from operations is $55.61 M

What is C4 Therapeutics annual CFO year-on-year change?

Over the past year, CCCC annual cash flow from operations has changed by -$899.00 K (-0.85%)

What is C4 Therapeutics quarterly cash flow from operations?

The current quarterly CFO of CCCC is -$24.13 M

What is the all time high quarterly CFO for C4 Therapeutics?

C4 Therapeutics all-time high quarterly cash flow from operations is -$4.97 M

What is C4 Therapeutics quarterly CFO year-on-year change?

Over the past year, CCCC quarterly cash flow from operations has changed by +$6.57 M (+21.41%)

What is C4 Therapeutics TTM cash flow from operations?

The current TTM CFO of CCCC is -$71.23 M

What is the all time high TTM CFO for C4 Therapeutics?

C4 Therapeutics all-time high TTM cash flow from operations is -$16.67 M

What is C4 Therapeutics TTM CFO year-on-year change?

Over the past year, CCCC TTM cash flow from operations has changed by +$40.72 M (+36.37%)